Urothelial Carcinoma
📧 Sign up to get email alerts when something new happens for Urothelial Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: A Phase 1 Clinical Trial of AUR106 in Patients With Relapsed Advanced Malignancies [Phase 1]
Phase 1 trial of AUR106 in relapsed advanced malignancies has been terminated; the document provides a status update on this study.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC [Phase 2]
Phase 2 clinical trial evaluating intravesical gemcitabine and docetaxel for high-risk, BCG-unresponsive non-muscle-invasive bladder cancer;…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer [Phase 1]
Phase 1 clinical trial update for BMS-986504 in combination with standard-of-care therapy for solid tumors, including diffuse pleural mesoth…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001) [Phase 1, Phase 2]
Phase 1/2 clinical trial update for AVZO-103 as a single agent and in combination therapy for locally advanced or metastatic urothelial carc…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Study of GEN1106 in Participants With Solid Tumors [Phase 1]
Phase 1 clinical trial update for GEN1106 in solid tumors, with a focus on urothelial carcinoma, currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors [Phase 1]
Phase 1 trial comparing HLX18 to nivolumab (Opdivo) in patients with multiple resected solid tumors, including esophageal/gastric cardia can…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan Versus Standard of Care in the Treatment of Advanced Urothelial Cancer [Phase 3]
This Phase 3 trial is evaluating pembrolizumab plus sacituzumab govitecan versus standard of care for locally advanced, unresectable, or met…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: ARID1A and/or KDM6A Mutation and CXCL13 Expression [Phase 2]
Phase 2 clinical trial update from MD Anderson investigating ARID1A and/or KDM6A mutation status and CXCL13 expression in urothelial cancers…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing [Phase 3]
This trial update describes a continued access study for participants who benefit from Pfizer-sponsored avelumab parent studies that are clo…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG
Expanded-access treatment program for the investigational gene therapy Cretostimogene Grenadanorepvec to treat non-muscle-invasive bladder c…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study to Survey Adults in South Korea With Cancer Who Receive PADCEV Injection
Astellas Korea is recruiting adults in South Korea for a survey study of cancer patients who receive PADCEV injections.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Comparing the New Anti-cancer Drug Eribulin With Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial Cancer [Phase 3]
Phase 3 clinical trial update evaluating eribulin plus standard chemotherapy versus standard chemotherapy alone for metastatic urothelial ca…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer [Phase 1]
This Clinical Trial Update describes a Phase 1 study evaluating the addition of BAY 1895344 to standard chemotherapy (cisplatin or cisplatin…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy [Phase 1]
A Phase 1 clinical trial is investigating the combination of Erdafitinib and Enfortumab Vedotin for metastatic bladder/urothelial cancers af…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer [Phase 2]
This Phase 2 trial update tests atezolizumab with or without eribulin mesylate in patients with recurrent locally advanced or metastatic uro…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors [Phase 1, Phase 2]
This is a Phase 1/2 clinical trial evaluating BMS-986340 as monotherapy and in combination with nivolumab or docetaxel across several advanc…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy [Phase 1]
Phase 1 clinical trial evaluating pembrolizumab in combination with CA-4948 for progressive metastatic urothelial cancer, currently recruiti…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma [Phase 1]
Phase 1 clinical trial update on QXL138AM assessing safety, pharmacokinetics, and preliminary efficacy in patients with solid tumors and mul…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Enfortumab Vedotin and Pembrolizumab in People With Bladder Cancer [Phase 2]
A Phase 2 clinical trial evaluating the combination of Enfortumab Vedotin and Pembrolizumab in patients with urothelial carcinoma is current…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction [Phase 1]
Phase 1 trial evaluating veliparib, paclitaxel, and carboplatin in patients with various metastatic or unresectable solid tumors and liver o…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Immune-Stromal Landscape in Muscle-Invasive Bladder Cancer
A ClinicalTrials.gov entry describes a study evaluating the immune-stromal landscape in muscle-invasive bladder cancer, sponsored by Assiut …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: SYS6002 vs Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma [Phase 3]
A Phase 3 trial evaluating SYS6002 versus standard chemotherapy in locally advanced or metastatic urothelial carcinoma; the study is not yet…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Pembrolizumab in Muscle-invasive Bladder Cancer [Phase 2]
A Phase 2 clinical trial evaluating pembrolizumab for muscle-invasive bladder cancer and urothelial carcinoma is currently active but not re…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study of Two Dosing Schedules of Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment for Metastatic Bladder Cancer [Phase 2]
Phase 2 trial evaluating two dosing schedules of atezolizumab in combination with gemcitabine and cisplatin as first-line therapy for metast…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer [Phase 1]
Phase 1 clinical trial evaluating GB-4362 in combination with Enfortumab Vedotin and Pembrolizumab for urothelial carcinoma is currently rec…